INCIDENCE OF SKELETAL COMPLICATIONS IN PATIENTS WITH BONE METASTATIC PROSTATE CANCER AND HORMONE REFRACTORY DISEASE: PREDICTIVE ROLE OF BONE RESORPTION AND FORMATION MARKERS EVALUATED AT BASELINE
To access this article, please choose from the options below
PII: S0022-5347(05)67149-2
© 2000 American Urological Association, Inc. Published by Elsevier Inc All rights reserved.

